Article
Identification of peptide vaccine candidates sharing among HLA-A3+, -A11+, -A31+, and -A33+ cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Feb 2004
Takedatsu Hiroko, Shichijo Shigeki, Katagiri Kazuko, Sawamizu Hiromi, Sata Michio, Itoh Kyogo
Abstract excerpt
PURPOSE: Only a few studies have been reported on CTL epitope peptides restricted with alleles other than HLA-A2 and -A24. The HLA-A11, -A31, and -A33 alleles share similar binding motifs with HLA-A3 and -A68 alleles, and, thus, are classified as an HLA-A3 supertype. This study tried to identify CTL epitope peptides as vaccine candidates sharing by HLA-A3(+), -A11(+), -A31(+), and -A33(+) cancer patients....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.